MILLIRE 2021 ANNUAL REPORT

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2021 Millî Reasürans Türk Anonim Şirketi (Currency: Turkish Lira (TL)) (Convenience Translation of Financial Statements and Related Disclosures and Footnotes Originally Issued in Turkish, See Note 2.1.1) Name Total assets Shareholders’ equity Retained earnings Profit for the year Audited Period Subsidiaries: Miltaş Turizm Inşaat Ticaret AŞ 5.688.344 5.119.204 8.636 190.948 Not Audited. 31 December 2021 Associates : Anadolu Hayat Emeklilik AŞ (consolidated) 51.499.992.517 1.884.514.731 108.600.909 699.988.065 Audited. 31 December 2021 In the current period TL 146.997.494 (December 31, 2021: 110.657.245) of income is obtained from associates and TL 148.939 of income is obtained from subsidiaries (December 31, 2020: TL 63.549) through equity accounted consolidation method. 10 Reinsurance assets and liabilities As of December 31, 2021, and 2020, outstanding reinsurance assets and liabilities of the Group in accordance with existing reinsurance contracts are as follows: Reinsurance assets December 31, 2021 December 31, 2020 Unearned premiums reserves, ceded (Note 17) 1.563.331.963 1.089.324.599 Outstanding claims reserve, ceded (Note 4.2), (Note 17) 2.957.988.891 2.179.921.969 Receivables from reinsurance companies (Note 12) 467.249.577 261.679.932 Cash deposited to reinsurance companies 631.657.238 397.198.168 Total 5.620.227.669 3.928.124.668 There are no impairment losses recognized for reinsurance assets. Reinsurance liabilities December 31, 2021 December 31, 2020 Payables to the reinsurers related to premiums written (Note 19) 1.243.712.653 622.634.390 Deferred commission income (Note 19) 202.730.004 135.727.041 Cash deposited by reinsurance companies 7.358.088 5.458.061 Commission payables to the reinsurers related to written premiums (Note 19) 8.390.642 - Total 1.462.191.387 763.819.492 228 MİLLÎ REASÜRANS ANNUAL REPORT 2021 ACTIVITIES AND MAJOR DEVELOPMENTS RELATED TO ACTIVITIES GENERAL INFORMATION FINANCIAL RIGHTS PROVIDED TO THE MEMBERS OF THE GOVERNING BODY AND SENIOR EXECUTIVES RESEARCH & DEVELOPMENT ACTIVITIES